Clinical Trials Browser

Phase 2/3 × isatuximab × Other hematologic neoplasm × Clear all

NCT06860269 2026-02-10

GRAALL-2024

Phase 2/3 Recruiting

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma